Kitzmiller Andrew S.
- SEC CIK
- 0001795272
No open-market purchases or sales filed in the past year.
Current role at each company
- Meridian Bioscience IncExecutive Vice President & CFOas of Jan 31, 2023
- HI Hillenbrand, Inc.VP, CAO and Controlleras of Jan 4, 2022
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Kitzmiller Andrew S. as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
Meridian Bioscience Inc
Executive Vice President & CFO1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Feb 28, 2022 (view filing) | Feb 25 | 3 days | Kitzmiller Andrew S.EVP & CFO | PPurchase | +4.03K | $24.87 | +$100.2K | +53.7%11.5K after |